We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Siemens and SurgiVision to Develop MRI-Guided Cardiac Electrophysiology System

By HospiMedica International staff writers
Posted on 24 Sep 2009
Siemens Healthcare (Erlangen, Germany) and SurgiVision (Irvine, CA, USA) have announced an agreement for the codevelopment and commercialization of a real-time magnetic resonance image (MRI)-guided cardiac electrophysiology (EP) system for diagnosing and treating atrial fibrillation (AF). More...


The two companies are collaborating with the University of Utah (Salt lake City, USA) to develop a fully integrated, groundbreaking EP MRI system that promises to improve conventional catheter-based cardiac procedures. In May 2009, the university opened an integrated EP-MRI clinical and research lab, which provides real-time delayed enhancement MRI for treating AF patients. The MRI's three-dimensional (3D) imaging provides greater resolution of the heart tissue than the two-dimensional images typically used, giving physicians a more precise and powerful tool for diagnosis and treatment.

"Siemens' scanner technologies, platform for interactive real-time guidance, and market leadership in MRI are second to none. By bringing together Siemens' capabilities with SurgiVision's technologies and expertise in real-time MRI-guided interventions, we are well-positioned to deliver a fully integrated hardware, software, and catheter system that will provide real-time visualization within an intuitive physician interface and a procedure that eliminates radiation exposure," said Kimble Jenkins, CEO of SurgiVision. "Our close research collaboration with the University of Utah rounds out our team with deep clinical expertise and broad research capabilities."

"We are excited to work with SurgiVision in the development of these important technologies that have the potential to significantly improve therapies for patients suffering from cardiac arrhythmias, in particular atrial fibrillation," added Walter Märzendorfer, CEO of the MR division at Siemens Healthcare.

"We are refining image-based cardiac ablation procedures using MRI, which our research indicates has the potential to improve the accuracy of the ablation, prevent complications, and decrease the number of repeat procedures," said Nassir Marrouche, M.D., an electrophysiologist and director of the University of Utah's atrial fibrillation program.


Related Links:
Siemens Healthcare
SurgiVision
University of Utah


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.